Over 1,300 Enterprises and Institutions Apply for the 6th Future Healthcare 100 China List: Showcasing Chinese Innovators Shaping Global Healthcare
/
The continuous iteration of industry trends is bound to trigger a new round of transformation.The rapid development of the industry has also brought new opportunities to individuals and enterprises. Exploration of new technologies, new fields, and new drug modalities is becoming more proactive, with differentiation replacing homogenization. The pace of internationalization is accelerating, the industrial chain is continuously improving, and China’s ecosystem is nurturing pharmaceutical companies poised to change the world.
"Not in the spotlight, still groping forward in the dark."Never being daunted by difficulties or halting progress is a unique badge of courage in the medical field. Over the past year, China’s healthcare sector has marked an unparalleled and fresh starting point for its vigorous development, driven by investors dedicating themselves to life sciences; the emergence of digital acupuncture, internet-based healthcare, and other online diagnosis and treatment solutions; and significant clinical advancements in surgical robotics.
Established in 2015, the "Top 100 Future Healthcare Companies" list is the first domestic ranking focused on innovative healthcare companies that are not publicly listed, launched by VB100, VCBeat, and VCBeat. It aims to select innovative healthcare pioneers who truly represent the future of healthcare, identify the core forces driving the future healthcare industry, and promote innovation and transformation in the health and medical sectors. Since its inception, the list has become a barometer for investment in the healthcare sector, guiding development and investment trends in China’s healthcare innovation field both currently and in the foreseeable future, while providing reference and guidance for subsequent financing of innovative enterprises.
● A total of 151 companies secured financing, and 11 listed companies successfully went public.
Reviewing the enterprises listed in the 5th Future Healthcare 100, we can seeBai Xin An, Transcenta Holding, Gushengtang, Keymed Biosciences, Cofoe Medical, Lepu Biopharma, Mabwell Biosciences, Rayuan Gene, Starna Therapeutics, NeuraMed Technology, Yihua PharmaInternal11Companies have been successfully going public one after another.
In addition, according to incomplete statistics from VB100,More than 151Following the release of the list, companies featured in the 5th Future Healthcare Top 100 secured a new round of financing.Cumulative Financing Exceeds RMB 46.47 Billion(excluding listed companies and overseas enterprises), among which 32 listed companies have raised a cumulative total of over RMB 500 million. The Innovative Pharmaceuticals List topped the ranking in terms of the number of funded companies, with 46 enterprises, followed by the Innovative Medical Devices List with 41 enterprises. The Innovative Pharmaceuticals List also led in total funding amount, with a cumulative RMB 16.38 billion, followed by the Medical Services List with a cumulative RMB 14.29 billion.
● List/Award Registration Concluded; Review and Verification Underway
On March 15, 2022, following three months of preparation and diligent efforts, the submission phase for the 6th “Top 100 Future Healthcare Companies” list was successfully concluded. A total of over 1,300 companies, institutions, and industrial parks submitted applications. The selection process will be based on core criteria such as valuations by investment institutions, cumulative funding amounts, corporate growth rates, creditworthiness, and reputation. Currently, the company rankings and awards have entered the stages of information verification and expert review.
Self-Declaration and Third-Party Recommendation:
December 10, 2021 - March 15, 2022
Information Review and First-Round Evaluation:
March 16, 2022 - March 20, 2022
Expert Panel Cross-Review:
March 21, 2022 - March 30, 2022
Final Review and Approval, Report Writing:
March 31, 2022 - April 20, 2022
The final results of the 6th Future Healthcare Top 100 List will be announced at the awards dinner of the 6th Future Healthcare Top 100 Conference, held from April 22–24, 2022, in Shishan, Suzhou, Jiangsu Province. All listed companies and institutions, as well as award winners, will be invited to attend the awards dinner.
"Future Healthcare Top 100 Enterprises Growth Analysis Report"It is a key component of the "Future Healthcare 100" list. Based on the roster of the top 100 companies, we conduct an in-depth analysis of how these enterprises have grown from small startups into unicorns in the medical and health sector. What factors have propelled their development at each critical milestone?The report will select a number of representative companies and deconstruct their development trajectories—spanning the start-up, growth, transformation, and maturity stages—to identify the key drivers behind their transformations at each stage.
The report will also examine industrial evolution from a temporal trend perspective. By comparing multi-dimensional data of listed companies across previous years, it evaluates the future core forces in healthcare across various dimensions—including geographic distribution, technological advancement, capital support, policy orientation, and growth rate—thereby redefining the growth paradigm for future healthcare enterprises.
Here, we aim to targetEnterprises that have already registered for the main list and are valued at over RMB 500 millionCall for Participation: If you are interested in helping us further improve the report by serving as a data-supporting enterprise for our analysis, please feel free to contact us.
Contact for Case Report Submissions
● Mapping the Industry Landscape, Telling China’s Story: The 2022 Top 100 Future Healthcare Companies Conference Held with Strong Momentum
From “Eye of the Storm,” “Species Big Bang,” “Tide Direction ING,” and “New Growth of Life” to “The Calculation of Life”; from 20 guests, 150 companies, and 400 attendees at the inaugural event to a cumulative total of over 1,000 domestic and international speakers, more than 5,000 participating enterprises, over 20,000 attendees, and 5 million+ impressions... The Top 100 Future Healthcare Conference has grown alongside China’s medical and health industry, continuously expanding to become the largest-scale and most information-rich summit integrating industry and capital within China’s healthcare innovation sector.
The 6th Future Healthcare Top 100 Conference will be held at the Shishan International Convention Center in Suzhou, Jiangsu Province. This year, we will collaborate with embassies from various countries to jointly host roadshows for global healthcare innovation projects. Embarking with a renewed vision, we will focus on “China’s Story,” ground ourselves in innovation, and faithfully document the trajectory of the global healthcare industry. We will identify leading innovative enterprises in the sector and analyze industry hotspots from five dimensions: policy orientation, technological frontiers, capital perspectives, industrial innovation, and market demand. By interpreting development trends in the future healthcare industry, we aim to drive transformation in the innovative healthcare sector. Our goal is to gather core industry forces, promote transformative change in innovative healthcare, and build a comprehensive communication and matchmaking platform for the entire medical and health industry chain.
/
Acknowledgments to the aforementioned investment institutions
In solicitation and selection activities such as enterprise recommendations, valuation reviews, and project evaluations
Support for VCBeat's 2022 7th Future Healthcare 100 List
Conference Dates: April 22-24, 2022
Conference Venue: Shishan International Convention Center, Suzhou, China
Limited-Time Offer: Conference All-Access Pass
Purchase Channels:Search for the “VB100” mini program on WeChat to make a purchase.
Two types of general admission tickets are available for public sale at this conference:
899 Yuan [VB100 All-Access Pass, Meals Not Included],RMB 1,299 [VB100 All-Access Pass with Meals],Limited-Time Offer · All-Access Conference PassSave ¥630 off the original price, now as low as ¥269Onset:
Your Trust Entitles You to the Following Benefits:
1. Forum + Exhibition + Interactive Activities Pass (Separate registration required for certain segments such as LPGP)
2. On-Site Resource Coordination Group Chat
3. Guest-authorized PPTs, conference proceedings, public reports, and other restricted materials
4. Lunch vouchers during the conference (only for those with meal tickets)
Special Note:
1. Duration of This Limited-Time OfferUpdates on Key Milestones from Today Until the Next Meeting;
2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is unveiled,Increase by 100 yuan each time until the original price is restored;
3、After this limited-time offer ends,Ticket prices will rise to 369 yuan.Qi
Scan the QR code to register for the 2022 · 6th Future Healthcare Top 100 Conference
Gentle Reminder:
1. The venue for this conference is located in the city center, where there are slightly more concurrent conferences during the same time period.Limited hotel availability in the surrounding area, it is recommended to book your hotel in advance for convenient access to the conference venue;
2. The conference has opened an exclusive discounted booking channel for attendees,Covering 7 hotels within a 3-kilometer radius, interested attendees may scan the QR code to access the mini-program for reservation;
Scan the QR code for discounted hotel reservations during the conference.
Consultation for the 2022 Future Healthcare Top 100 Conference
